Silo Pharma, Inc. (SILO)
1.34
+0.05
(+3.88%)
USD |
NASDAQ |
Nov 06, 10:24
Silo Pharma Market Cap : 1.512M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 1.456M |
| November 04, 2026 | 1.501M |
| November 03, 2026 | 1.445M |
| November 02, 2026 | 1.366M |
| October 30, 2026 | 1.388M |
| October 29, 2026 | 1.411M |
| October 28, 2026 | 1.512M |
| October 27, 2026 | 1.456M |
| October 26, 2026 | 1.309M |
| October 23, 2026 | 1.332M |
| October 22, 2026 | 1.332M |
| October 21, 2026 | 1.354M |
| October 20, 2026 | 1.354M |
| October 19, 2026 | 1.275M |
| October 16, 2026 | 1.332M |
| October 15, 2026 | 1.354M |
| October 14, 2026 | 1.354M |
| October 13, 2026 | 1.377M |
| October 12, 2026 | 1.682M |
| October 09, 2026 | 1.659M |
| October 08, 2026 | 1.636M |
| October 07, 2026 | 1.625M |
| October 06, 2026 | 1.636M |
| October 05, 2026 | 1.682M |
| October 02, 2026 | 1.646M |
| Date | Value |
|---|---|
| October 01, 2026 | 1.693M |
| September 30, 2026 | 1.704M |
| September 29, 2026 | 1.817M |
| September 28, 2026 | 1.862M |
| September 25, 2026 | 1.975M |
| September 24, 2026 | 1.975M |
| September 23, 2026 | 1.998M |
| September 22, 2026 | 1.941M |
| September 21, 2026 | 1.969M |
| September 18, 2026 | 2.077M |
| September 17, 2026 | 1.941M |
| September 16, 2026 | 1.986M |
| September 15, 2026 | 2.190M |
| September 14, 2026 | 2.336M |
| September 11, 2026 | 2.370M |
| September 10, 2026 | 2.375M |
| September 09, 2026 | 2.426M |
| September 08, 2026 | 2.573M |
| September 04, 2026 | 2.709M |
| September 03, 2026 | 2.765M |
| September 02, 2026 | 2.822M |
| September 01, 2026 | 2.754M |
| August 31, 2026 | 2.799M |
| August 28, 2026 | 2.867M |
| August 27, 2026 | 2.867M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.586B |
| Alnylam Pharmaceuticals, Inc. | 21.15B |
| Anika Therapeutics, Inc. | 216.94M |
| Savara, Inc. | 955.11M |
| Vericel Corp. | 2.648B |
Market Cap Related Metrics
| PS Ratio | 21.81 |
| Price to Book Value | 0.3096 |
| Price | 1.34 |
| Earnings Yield | -398.4% |